COVID-19 vaccination in the United Arab Emirates

COVID-19 vaccination in the United Arab Emirates
DateDecember 2020 – November 2022
LocationUnited Arab Emirates
CauseCOVID-19 pandemic in the United Arab Emirates
TargetImmunization against COVID-19
Organised byMinistry of Health
Participants16,444,844 total doses administered
  • First dose: 7,684,876
  • Second dose: 6,765,065
Outcome
  • 77.70% of the Emirati population has received at least one dose of a vaccine
  • 68.40% has received both doses of a vaccine
WebsiteUnited Arab Emirates COVID-19 Data

The COVID-19 vaccination in the United Arab Emirates was a national immunization campaign in the United Arab Emirates in response to the COVID-19 pandemic.

The vaccination campaign began in December 2020 after its authorization of emergency use of Sinopharm BIBP COVID-19 vaccine.

The Ministry of Health and Prevention (MOHAP) had approved six COVID-19 vaccines; the following are: Sinopharm BIBP, Pfizer-BioNTech, Sputnik V, Oxford–AstraZeneca, Moderna, and Sinopharm CNBG.

The United Arab Emirates ended all of its COVID-19 related public health measures on 6 November 2022.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.